What is the appropriate management of a patient with hypertension?

Management of Hypertension

For most patients with hypertension, initiate combination therapy with two first-line antihypertensive agents—specifically a calcium channel blocker (CCB) combined with either a renin-angiotensin system (RAS) blocker (ACE inhibitor or ARB) or a thiazide/thiazide-like diuretic—while simultaneously implementing lifestyle modifications including sodium restriction, weight loss if overweight, regular physical activity, and the DASH diet. 1, 2

Initial Diagnostic Approach

Before starting treatment, confirm the diagnosis using out-of-office blood pressure measurements:

• Ambulatory BP monitoring (ABPM) is the gold standard
• Home BP monitoring (HBPM) is an acceptable alternative
• This step is critical to exclude white coat hypertension and confirm true hypertension 3

Screen for secondary causes of hypertension, particularly in:

• Younger patients with new-onset hypertension
• Resistant hypertension cases
• Sudden worsening of previously controlled BP

Blood Pressure Targets

Target BP goals are <130/80 mmHg for most adults with confirmed hypertension 1, 3. This represents the current AHA/ACC standard, though this is more aggressive than some international guidelines.

First-Line Pharmacologic Treatment

Start with combination therapy using two drugs from different classes 2:

1. Preferred combinations:

   • CCB + RAS blocker (ACE inhibitor or ARB)
   • CCB + thiazide/thiazide-like diuretic
   • RAS blocker + thiazide/thiazide-like diuretic

2. Rationale: Most patients require at least two medications to achieve BP control, and starting with combination therapy improves adherence and achieves target BP faster 3

3. Dosing strategy: Use maximum tolerated doses before adding additional agents 4

Essential Lifestyle Modifications

Implement these non-pharmacologic interventions for all patients 1, 2:

• Sodium restriction: Reduce dietary sodium intake
• Weight loss: For overweight/obese patients (BMI ≥25)
• Physical activity: Regular aerobic exercise
• DASH diet: Emphasize fruits, vegetables, whole grains, low-fat dairy
• Alcohol reduction: Limit intake
• Smoking cessation: If applicable

Management of Resistant Hypertension

Resistant hypertension is defined as BP remaining above target despite adherence to three antihypertensive agents (including a CCB, RAS blocker, and diuretic at optimal doses) 4.

Step-by-step approach:

1. First, verify true resistance:

   • Confirm with ABPM/HBPM
   • Assess medication adherence
   • Exclude secondary causes
   • Review interfering substances (NSAIDs, decongestants, etc.)

2. Reinforce lifestyle modifications, especially sodium restriction 2

3. Add spironolactone (low-dose) as the fourth-line agent 2, 4

   • This is the strongest evidence-based recommendation from the PATHWAY-2 trial
   • Most effective fourth-line agent for resistant hypertension

4. If spironolactone is not tolerated or contraindicated, consider alternatives 2, 4:

   • Eplerenone (alternative mineralocorticoid receptor antagonist)
   • Amiloride (potassium-sparing diuretic)
   • Doxazosin (alpha-blocker)
   • Bisoprolol (beta-blocker)
   • Higher-dose thiazide or loop diuretic
   • Centrally acting agents (clonidine)

5. Renal denervation may be considered in highly selected cases at experienced centers after multidisciplinary assessment and shared decision-making 2

Special Considerations for Atherosclerotic Renal Artery Stenosis

Do not routinely perform renal artery revascularization for hypertension management 1. Multiple RCTs show no benefit over medical therapy alone for most patients.

Medical management is preferred and should include:

• Optimal antihypertensive regimen with RAS blocker
• High-intensity statin
• Antiplatelet therapy
• Smoking cessation
• Glycemic control if diabetic

Revascularization may be considered only in highly select cases 1:

• Progressively worsening kidney function despite medical therapy
• Recurrent acute heart failure/flash pulmonary edema
• Fibromuscular dysplasia (non-atherosclerotic disease)—angioplasty alone without stenting may be curative, especially in younger women

Common Pitfalls to Avoid

• Don't rely solely on office BP measurements for diagnosis—always confirm with out-of-office monitoring
• Don't add multiple medications sequentially at suboptimal doses—maximize doses before adding agents
• Don't overlook medication non-adherence as a cause of apparent resistant hypertension
• Don't forget to screen for and discontinue interfering substances (NSAIDs, oral contraceptives, decongestants, licorice, etc.)
• Don't pursue renal artery revascularization routinely—medical therapy is superior for atherosclerotic disease

Comprehensive Cardiovascular Risk Management

Remember that hypertensive patients require comprehensive cardiovascular risk reduction beyond BP control alone 1:

• Lipid management with statins when indicated
• Antiplatelet therapy for appropriate patients
• Diabetes management
• Smoking cessation